国药控股发布2026年9月15日临时股东大会代理投票表格，仅涉及第七届董事会成员连任

SINOPHARM GROUP CO. LTD.*
(A joint stock limited company incorporated in the People’s Republic of China with limited liability
and carrying on business in Hong Kong as )
(Stock Code: 01099)

FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING
TO BE HELD ON TUESDAY, 15 SEPTEMBER 2026

Number of shares to which this
form of proxy relates (Note 1)

I/We (Note 2)
of (address)
being the holder(s) of domestic shares/H shares (Note 3) of
RMB1.00 each in the share capital of Sinopharm Group Co. Ltd. (the “Company”), hereby appoint the Chairman of the
(Note 4)
meeting or
of (address) ,
as my/our proxy(ies) to attend the extraordinary general meeting of the Company to be held at Meeting Room 1401,
Sinopharm Group Building, No. 385, East Longhua Road, Huangpu District, Shanghai, the People’s Republic of China
(the “PRC”) at 9:00 a.m. on Tuesday, 15 September 2026 (the “EGM”) or any adjournment thereof and to vote at such
meeting or at any adjournment thereof in respect of the resolutions set out in the notice of the EGM as hereunder
indicated on behalf of me/us, or if no such indication is given, as my/our proxy(ies) thinks fit.

ORDINARY RESOLUTIONS FOR (Note 5) AGAINST (Note 5)
1. To consider and approve (if thought fit) the re-election of Mr.
Lian Wanyong as an executive Director of the seventh session of
the board of the Company (the “Board”), and to authorize the
Board to determine his remuneration and to authorize the
chairman of the Board (the “Chairman”) or any executive
Director of the Company to enter into the service contract or such
other documents or supplemental agreements or deeds with him.
2. To consider and approve (if thought fit) the re-election of Mr.
Yang Binghua as an executive Director of the seventh session of
the Board, and to authorize the Board to determine his
remuneration and to authorize the Chairman or any executive
Director of the Company to enter into the service contract or such
other documents or supplemental agreements or deeds with him.
3. To consider and approve (if thought fit) the re-election of Mr. Jin
Bin as a non-executive Director of the seventh session of the
Board, and to authorize the Board to determine his remuneration
and to authorize the Chairman or any executive Director of the
Company to enter into the service contract or such other
documents or supplemental agreements or deeds with him.
4. To consider and approve (if thought fit) the re-election of Mr.
Chen Qiyu as a non-executive Director of the seventh session of
the Board, and to authorize the Board to determine his
remuneration and to authorize the Chairman or any executive
Director of the Company to enter into the service contract or such
other documents or supplemental agreements or deeds with him.



* The Company is registered as a non-Hong Kong company under the Hong Kong Companies Ordinance under its
Chinese name and the English name “Sinopharm Group Co. Ltd.”.
ORDINARY RESOLUTIONS FOR (Note 5) AGAINST (Note 5)
5. To consider and approve (if thought fit) the re-election of Mr. Zu
Jing as a non-executive Director of the seventh session of the
Board, and to authorize the Board to determine his remuneration
and to authorize the Chairman or any executive Director of the
Company to enter into the service contract or such other
documents or supplemental agreements or deeds with him.
6. To consider and approve (if thought fit) the re-election of Mr.
Xing Yonggang as a non-executive Director of the seventh
session of the Board, and to authorize the Board to determine his
remuneration and to authorize the Chairman or any executive
Director of the Company to enter into the service contract or such
other documents or supplemental agreements or deeds with him.
7. To consider and approve (if thought fit) the re-election of Mr. Ma
Yue as a non-executive Director of the seventh session of the
Board, and to authorize the Board to determine his remuneration
and to authorize the Chairman or any executive Director of the
Company to enter into the service contract or such other
documents or supplemental agreements or deeds with him.
8. To consider and approve (if thought fit) the re-election of Mr.
Chen Yuqing as a non-executive Director of the seventh session
of the Board, and to authorize the Board to determine his
remuneration and to authorize the Chairman or any executive
Director of the Company to enter into the service contract or such
other documents or supplemental agreements or deeds with him.
9. To consider and approve (if thought fit) the re-election of Mr.
Wen Deyong as a non-executive Director of the seventh session
of the Board, and to authorize the Board to determine his
remuneration and to authorize the Chairman or any executive
Director of the Company to enter into the service contract or such
other documents or supplemental agreements or deeds with him.
10. To consider and approve (if thought fit) the re-election of Ms. Li
Ying as a non-executive Director of the seventh session of the
Board, and to authorize the Board to determine her remuneration
and to authorize the Chairman or any executive Director of the
Company to enter into the service contract or such other
documents or supplemental agreements or deeds with her.
11. To consider and approve (if thought fit) the re-election of Mr. Li
Peiyu as an independent non-executive Director of the seventh
session of the Board, and to authorize the Board to determine his
remuneration and to authorize the Chairman or any executive
Director of the Company to enter into the service contract or such
other documents or supplemental agreements or deeds with him.
12. To consider and approve (if thought fit) the re-election of Mr. Wu
Tak Lung as an independent non-executive Director of the
seventh session of the Board, and to authorize the Board to
determine his remuneration and to authorize the Chairman or any
executive Director of the Company to enter into the service
contract or such other documents or supplemental agreements or
deeds with him.
13. To consider and approve (if thought fit) the re-election of Mr. Yu
Weifeng as an independent non-executive Director of the seventh
session of the Board, and to authorize the Board to determine his
remuneration and to authorize the Chairman or any executive
Director of the Company to enter into the service contract or such
other documents or supplemental agreements or deeds with him.
ORDINARY RESOLUTIONS FOR (Note 5) AGAINST (Note 5)
14. To consider and approve (if thought fit) the re-election of Mr. Shi
Shenghao as an independent non-executive Director of the
seventh session of the Board, and to authorize the Board to
determine his remuneration and to authorize the Chairman or any
executive Director of the Company to enter into the service
contract or such other documents or supplemental agreements or
deeds with him.
15. To consider and approve (if thought fit) the re-election of Mr.
Chen Weiru as an independent non-executive Director of the
seventh session of the Board, and to authorize the Board to
determine his remuneration and to authorize the Chairman or any
executive Director of the Company to enter into the service
contract or such other documents or supplemental agreements or
deeds with him.




Dated this day of 2026 Signature (Note 6):

Notes:

1. Please insert the number of shares of the Company registered in your name(s) to which this proxy relates. If a number
is inserted, this form of proxy will be deemed to relate only to those shares. If no number is inserted, the form of proxy
will be deemed to relate to all shares registered in your name(s) (whether alone or jointly with others).

2. Please insert the full name(s) (in Chinese or English) and address(es) as registered in the register of members of the
Company in Block Letters.

3. Please insert the number of shares of the Company registered in your name(s) and delete as appropriate.

4. If any proxy other than the Chairman of the meeting of the Company is preferred, please strike out the words “the
Chairman of the meeting or” and insert the name and address of the proxy desired in the space provided. A shareholder
may appoint one or more proxies to attend and vote on his/her behalf. A proxy need not be a shareholder of the
Company. A proxy of a shareholder who has appointed more than one proxy may only vote on a poll. Any alteration
made to this form of proxy must be initialed by the person(s) who sign(s) it.

5. Important: If you wish to vote for any resolution, please put a tick in the box marked “FOR” or insert the number of
shares held by you. If you wish to vote against any resolution, please put a tick in the box marked “AGAINST” or
insert the number of shares held by you. If you do not indicate how you wish your proxy to vote, your proxy will be
entitled to exercise his discretion. Your proxy will also be entitled to vote at his discretion on any resolution properly
put to the EGM other than those referred to in the notice of the EGM.

6. This form of proxy must be signed by you or your attorney duly authorised in writing or, in the case of a legal person,
must be either executed under its seal or under the hand of its director or other attorney duly authorised to sign the
same. In case of joint holders, this form of proxy must be signed by the shareholder whose name stands first in the
register of members of the Company.

7. To be valid, for holders of H shares, this form of proxy and, if such proxy is signed by a person on behalf of the
appointer pursuant to a power of attorney or other authority, a notarially certified copy of that power of attorney or
other authority must be delivered to the H share registrar of the Company in Hong Kong, Computershare Hong Kong
Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong not less than
24 hours before the time appointed for holding the EGM (or any adjournment thereof). For holders of domestic shares,
this form of proxy and, if such proxy is signed by a person on behalf of the appointer pursuant to a power of attorney or
other authority, a notarially certified copy of that power of attorney or other authority must be delivered to the office of
the Company in the PRC at Room 1413, Sinopharm Group Building, No. 385, East Longhua Road, Huangpu District,
Shanghai, 200023, the PRC not less than 24 hours before the time appointed for holding the EGM (or any adjournment
thereof).

8. In the case of joint holders of shares of the Company, only holder whose name stands first in the register of members of
the Company shall alone be entitled to vote at the EGM either in person or by proxy in respect of such shares.

9. The EGM is expected to be held less than half a day. Shareholders and their proxies who attend the meeting shall be
responsible for their own transportation and accommodation expenses. Shareholders shall produce their identity
documents when attending the EGM.